Achieve Life Sciences, Inc. (ACHV) Net income 2016–2025
Achieve Life Sciences, Inc. (ACHV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$54.6MFY2025 · since FY2016: -$1.2M → -$54.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.6M | -37.2% |
| FY2024 | -$39.8M | -33.6% |
| FY2023 | -$29.8M | +29.6% |
| FY2022 | -$42.4M | -27.7% |
| FY2021 | -$33.2M | -125.1% |
| FY2020 | -$14.7M | +10.2% |
| FY2019 | -$16.4M | -29.2% |
| FY2018 | -$12.7M | -19.9% |
| FY2017 | -$10.6M | -757.6% |
| FY2016 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACHV financial trends
ACHV RevenueACHV Net marginACHV Gross profitACHV Gross marginACHV Operating incomeACHV Operating marginACHV Operating cash flowACHV Free cash flowACHV Capital expendituresACHV Return on equityACHV Stock buybacksACHV Dividends paidACHV Total assetsACHV Total liabilitiesACHV Shareholders’ equityACHV overview →